Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
EPO Biosimilars - The Future of Erythropoietin Market
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Aug, 2016| No. of Pages : 45
Please make your selection :
Electronic Access - Single User License
US$ 600.00
CD-ROM Mail Delivery
US$ 700.00
Hard Copy Mail Delivery
US$ 700.00
Electronic Access - Multi-User License
US$ 1000.00
1. Analyst View
2. Research Methodology
3. Industry Trends and Drivers
3.1 Biosimilars Opens Array of Opportunity for Market Growth
3.2 Growing Geriatric Population
3.3 Increasing Incidences of Chronic Diseases
3.4 Ability to Curb Healthcare Cost
4. Industry Challenges
4.1 High Prices
4.2 Stringent Regulatory Processes
4.3 Threat from Substitutes
5. Global Protein Therapeutics Market
5.1 Protein Therapeutics Market Vs Pharmaceutical Market
5.2 Current and Future Market Analysis for 2022
5.3 Market Segmentation
6. Erythropoietin Market - Introduction
7. Global Erythropoietin Market Outlook to 2022
8. Market Segmentation
8.1 By Type
8.1.1 Biologic
8.1.2 Biosimilar
8.2 By Application
8.3 By Drug
9. Global Erythropoietin Market by Geography
9.1.1 US
9.1.2 Europe
9.1.3 Asia-Pacific
10. Pipeline Analysis of Erythropoietin
11. Competitive Landscape
11.1 Share of Major Players
11.2 Key Players Analysis
11.2.1 Amgen Inc.
11.2.2 Johnson & Johnson
11.2.3 Roche Group
11.2.4 Pfizer Inc.
11.2.5 Novartis
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact